期刊文献+

子宫内膜癌PCNA表达和雌孕激素受体的研究 被引量:3

Study on expression of PCNA and estrogen, progesterone receptors in endometrial carcinoma
下载PDF
导出
摘要 目的 :探讨子宫内膜癌 (endometrialcarcinoma ,EMC)增殖活性以及雌、孕激素受体的表达与临床病理特性、预后的关系。方法 :采用免疫组织化学方法检测 74例子宫内膜癌增殖细胞核抗原 (proliferatingcellnucleusantigen ,PCNA)、雌激素受体 (estrogenreceptor ,ER)、孕激素受体 (progesteronereceptor ,PR)含量。结果 :PCNA在对照组和EMC中的阳性率分别为 30 .0 %和 82 .4% ,差异有显著性 (P <0 .0 1) ;在不同分化程度的EMC中PCNA阳性表达率差异无显著性 ,但PCNA阳性指数 (PI)评分 ,WD明显低于MD ,LD ,差异有显著性 (P <0 .0 0 1) ,且与EMC分化程度呈负相关(r = 0 .5 2 ,P <0 .0 1) ;PCNAPI评分与EMC临床期别之间呈正相关 (r =0 .5 5 ,P <0 .0 1)。EMC中ER ,PR阳性例数分别为 49例 (6 6 .2 % )和 5 6例 (75 .7% ) ,PCNA表达与ER ,PR受体之间呈负相关 ,r值分别为 - 0 .42 (P <0 .0 5 )和 - 0 .5 1(P <0 .0 5 )。结论 :ER和PR阳性、PCNAPI评分较低的子宫内膜癌 ,肿瘤细胞异型性小 ;反之 ,表现为侵犯邻近组织、扩散、转移等恶性生物学行为。ER ,PR和PCNA表达之间有明显互补性。PCNA表达结合ER ,PR检测具有方法简单、组织无需特殊处理等特点 ,适于对常规病理切片作回顾性研究 ,对鉴别肿瘤性质、预测预后均有? Objective To investigate the proliferating ability of tumor cells in 74 cases with endometrial carcinoma (EMC), as well as define the correlation between clinical pathology, prognostic features and estrogen receptor (ER), progesterone receptor (PR). Methods Proliferating cell nucleus antigen (PCNA) and ER/PR content were examined using immunohistochemical assay. Results PCNA was expressed in both benign hyperplasia and EMC, but positive rate in the latter was significantly higher than that in the former (82.4% vs 30.0%)(P<0.01). EMC well differentiated had lower proliferating index (PI) score than those moderately and poorly differentiated(P<0.001), and the PI score was negatively related to the grade of differentiation(r= 0.52, P<0.01). PI score in early cases (Ⅰ/Ⅱ) was significantly lower than that in advanced ones(Ⅲ/Ⅳ) (P<0.05), and the PI score was positively related to the clinical stages (r=0.55, P<0.01). Positive rates of ER, PR were 66.2% (49/74) and 75.7%(56/74) respectively, expression of PCNA was negatively related with ER and PR(r-0.42, 0.51,respectively,P<0.05). Conclusions EMC cells with poorer differentiation or in more advanced stages have faster proliferating ability and aggressive biological behavior. Expression of PCNA combined with detection of ER/PR not only apts to retrospective study, but also has some prognostic value.
出处 《湖南医科大学学报》 CSCD 北大核心 2001年第2期123-125,共3页 Bulletin of Hunan Medical University
关键词 子宫内膜肿瘤 增殖细胞核抗原 雌激素受体 孕激素受体 免疫组织化学 endometrial neoplasms proliferating cell nucleus antigen * receptor, estrogen receptor, progesterone immunohistochemistry
  • 相关文献

参考文献4

二级参考文献5

共引文献115

同被引文献19

  • 1史惠蓉,陈志敏,梁爱青.子宫内膜癌组织中Survivin和PCNA的表达[J].郑州大学学报(医学版),2005,40(3):408-410. 被引量:6
  • 2[2]Ohta M,Inoue H,Cotticelli MG,et al.The FHIT gene,spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint,is abnormal in digestive tract cancers.Cell,1996,84(4):587-597.
  • 3[3]Mori M,Mimori K,Shiraishi T,et al.Altered expression of Fhit in carcinoma and precarcin-omatous lesions of the esophagus.Cancer Res,2000,60(5):1177-1182.
  • 4[4]Rocco A,Schandl L,Chen J,et al.Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer.J Cancer Res Clin Oncol,2003,129(2):84-88.
  • 5[5]Andachi H,Yashima K,Koda M,et al.Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma.Br J Cancer,2002,87(4):441-445.
  • 6[6]Mascaux C,Martin B,Verdebout JM,et al.Fragile histidine triad protein expression in non-small cell lung cancer and correlation with Ki-67 and with p53.Eur Respir J,2003,21(5):753-758.
  • 7[7]Koch E,Fiedler W,Tannapfel A,et al.Alteration of the fragiletriad histidinetriad gene in intrahepatic cholangiocarcinoma.Eur J Gastroenterol Hepatol,2003,15(8):907-913.
  • 8[8]Pavelic K,Krizanac S,Cacev T,et al.Aberration of FHIT gene is associated with increased tumor prolifertion and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.Mol Med,2001,7(7):442-453.
  • 9[10]Murphy GA,Halliday D,McLennan AG.The Fhit tumor suppressor protein regulates the intracellular concerntration of diadenosine triphophate but not diadenosine tetraphosphate.Cancer Res,2000,60(9):2342-2344.
  • 10[11]Asish R,Chaudhuri AR,Israr A,et al.The tumor suppressor protein Fhit.A novel interaction with tubulin.J Biol Chem,1999,274(34):24378-24382.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部